Xiaoyan Bao

1.2k citations
38 papers · 912 indexed · h-index 17
Topics
Advanced Drug Delivery Systems (9 papers)Nanoplatforms for cancer theranostics (5 papers)Boron Compounds in Chemistry (5 papers)

In The Last Decade

Xiaoyan Bao

34 papers receiving 889 citations

Peers

Xiaoyan Bao
Comparison fields: 5 of 100
  • Biomedical Engineering 297
  • Materials Chemistry 269
  • Biomaterials 174
  • Molecular Biology 141
  • Renewable Energy, Sustainability and the Environment 134
Replace Qi‐Wen Chen with:
Qi‐Wen Chen China
Mónica P. A. Ferreira Finland
Yanru Ge China
Yongkang Yu China
Mubashir Hussain China
Daniel Crístian Ferreira Soares Brazil
Shazid Md. Sharker Bangladesh
Tianqi Nie China
Anand Kumar Meka Australia
Xiaoyan Bao relative to Qi‐Wen Chen China Qi‐Wen Chen's profile →
Citations per field
00.5×1.5×2.0×
Qi‐Wen Chen · 1×
Citations per year

Countries citing papers authored by Xiaoyan Bao

Since Specialization
Citations

This map shows the geographic impact of Xiaoyan Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Bao more than expected).

Fields of papers citing papers by Xiaoyan Bao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Bao. The network helps show where Xiaoyan Bao may publish in the future.

Co-authorship network of co-authors of Xiaoyan Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Bao. A scholar is included among the top collaborators of Xiaoyan Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Bao. Xiaoyan Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 0
5 1
6 13
7 47
8 14
9 25
10 3
11 7
12 35
13 48
14 10
15 1
16 36
17 41
18 47
19 22
20 46

About Xiaoyan Bao

Xiaoyan Bao is a scholar working on Pharmaceutical Science, Biomaterials and Radiology, Nuclear Medicine and Imaging, having authored 38 papers that have together received 912 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (9 papers), Nanoplatforms for cancer theranostics (5 papers) and Boron Compounds in Chemistry (5 papers). The work is most often cited by research in Pharmaceutical Science (121 citations), Biomaterials (174 citations) and Renewable Energy, Sustainability and the Environment (134 citations). Xiaoyan Bao has collaborated with scholars based in China, United States and Bulgaria. Frequent co-authors include Ping Yao, Kang Qian, Guangrui Xu, Zimu Li, Yimin Deng, Weiwei Zeng, Meiying Wu, Hanjie Zhang, Xiaoyuan Ji and Aiting Jiang. Their work appears in journals such as Nature Communications, Chemical Engineering Journal and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026